Related changes
Jump to navigation
Jump to search
Enter a page name to see changes on pages linked to or from that page. (To see members of a category, enter Category:Name of category). Changes to pages on your Watchlist are in bold.
List of abbreviations:
- N
- This edit created a new page (also see list of new pages)
- m
- This is a minor edit
- b
- This edit was performed by a bot
- (±123)
- The page size changed by this number of bytes
19 April 2024
|
m 00:36 | Esophageal squamous cell carcinoma 3 changes history +27 [Jwarner (3×)] | |||
m |
|
00:36 (cur | prev) -1 Jwarner talk contribs →Nivolumab monotherapy {{#subobject:10ee99|Regimen=1}} | |||
m |
|
00:35 (cur | prev) -1 Jwarner talk contribs →Regimen {{#subobject:d1dde0|Variant=1}} | |||
m |
|
00:35 (cur | prev) +29 Jwarner talk contribs →Camrelizumab monotherapy {{#subobject:c701c3|Regimen=1}} |
m 00:29 | Non-small cell lung cancer, nonsquamous diffhist -39 Jwarner talk contribs →Regimen variant #2, 5/500 x 4, then maintenance pem x 2y {{#subobject:1mwjm3|Variant=1}} |
18 April 2024
m 23:47 | Gastric cancer, HER2-positive diffhist -2 Jwarner talk contribs →Regimen {{#subobject:577cd6|Variant=1}} |
|
m 23:44 | Peripheral T-cell lymphoma 2 changes history +22 [Jwarner (2×)] | |||
m |
|
23:44 (cur | prev) +3 Jwarner talk contribs →References | |||
m |
|
23:44 (cur | prev) +19 Jwarner talk contribs →Gemcitabine monotherapy {{#subobject:7dbc1c|Regimen=1}} |
m 23:39 | Clear cell renal cell carcinoma diffhist +807 Jwarner talk contribs |
m 20:40 | Non-small cell lung cancer, ALK-positive diffhist +4 Jwarner talk contribs →Regimen {{#subobject:9cef11|Variant=1}} |
15 April 2024
20:16 | Classical Hodgkin lymphoma, pediatric diffhist 0 Warner-admin talk contribs |
20:07 | Hepatoblastoma diffhist -1 Warner-admin talk contribs |
|
20:04 | Rhabdomyosarcoma, pediatric 4 changes history +7 [Jwarner; Warner-admin (3×)] | |||
|
20:04 (cur | prev) -29 Warner-admin talk contribs →Low Risk | ||||
|
20:03 (cur | prev) +17 Warner-admin talk contribs →Intermediate Risk | ||||
|
19:57 (cur | prev) +17 Warner-admin talk contribs →High Risk | ||||
m |
|
17:02 (cur | prev) +2 Jwarner talk contribs |
20:01 | Gestational trophoblastic neoplasia diffhist -16 Warner-admin talk contribs |
m 19:20 | Multiple myeloma, consolidation and maintenance diffhist -1 Jwarner talk contribs →Thalidomide & Prednisolone (TP) {{#subobject:1agdc9|Regimen=1}} |
m 17:04 | CNS lymphoma diffhist +16 Jwarner talk contribs →Nordic Regimen, younger patients {{#subobject:e571ce|Regimen=1}} |
14 April 2024
m 17:35 | Urothelial carcinoma diffhist -13 Jwarner talk contribs →Preceding treatment |
m 17:33 | Testicular cancer diffhist +9 Jwarner talk contribs →Regimen variant #5, 45/500/100 (modified BEP) {{#subobject:fd61db|Variant=1}} |
|
m 17:29 | Non-small cell lung cancer, nonsquamous 2 changes history +78 [Jwarner (2×)] | |||
m |
|
17:29 (cur | prev) +45 Jwarner talk contribs →Maintenance after first-line therapy | |||
m |
|
17:28 (cur | prev) +33 Jwarner talk contribs →Consolidation after definitive therapy for inoperable disease |
m 17:23 | Multiple myeloma, consolidation and maintenance diffhist +140 Jwarner talk contribs |
|
m 17:21 | Mantle cell lymphoma 2 changes history +35 [Jwarner (2×)] | |||
m |
|
17:21 (cur | prev) +9 Jwarner talk contribs →Preceding treatment | |||
m |
|
17:20 (cur | prev) +26 Jwarner talk contribs →Brexucabtagene autoleucel monotherapy {{#subobject:4z3u14|Regimen=1}} |
m 17:19 | Low-grade glioma diffhist +10 Jwarner talk contribs →Regimen variant #3, continuous therapy {{#subobject:3871fe|Variant=1}} |
m 17:19 | Light-chain (AL) amyloidosis diffhist +24 Jwarner talk contribs →Relapsed or refractory |
m 17:16 | Glioblastoma diffhist +43 Jwarner talk contribs →Maintenance after first-line therapy |
m 12:49 | Ewing sarcoma diffhist +44 Jwarner talk contribs |
m 12:48 | Acute promyelocytic leukemia diffhist -36 Jwarner talk contribs |
m 12:43 | Diffuse large B-cell lymphoma diffhist +355 Jwarner talk contribs |
|
m 11:09 | Paroxysmal nocturnal hemoglobinuria 2 changes history +1,863 [Jwarner (2×)] | |||
m |
|
11:09 (cur | prev) +1,805 Jwarner talk contribs →Iptacopan monotherapy {{#subobject:aa617d |Regimen=1}} | |||
m |
|
10:43 (cur | prev) +58 Jwarner talk contribs →References |
|
m 10:41 | Drug index 2 changes history +31 [Jwarner (2×)] | |||
m |
|
10:41 (cur | prev) +56 Jwarner talk contribs →I | |||
m |
|
10:40 (cur | prev) -25 Jwarner talk contribs →I |
|
10:34 | Pheochromocytoma 2 changes history +1,840 [Jwarner (2×)] | |||
m |
|
10:34 (cur | prev) -223 Jwarner talk contribs →Sunitinib monotherapy {{#subobject:ec3261|Regimen=1}} | |||
|
10:33 (cur | prev) +2,063 Jwarner talk contribs →All lines of therapy |
13 April 2024
|
m 15:29 | Follicular lymphoma 6 changes history +606 [Jwarner (6×)] | |||
m |
|
15:29 (cur | prev) +82 Jwarner talk contribs →Maintenance after subsequent lines of therapy | |||
m |
|
15:27 (cur | prev) +55 Jwarner talk contribs →Consolidation after subsequent lines of therapy | |||
m |
|
15:25 (cur | prev) +227 Jwarner talk contribs →Maintenance after first-line therapy | |||
m |
|
15:22 (cur | prev) +204 Jwarner talk contribs →Consolidation after first-line therapy | |||
m |
|
15:17 (cur | prev) +11 Jwarner talk contribs →Observation | |||
m |
|
15:17 (cur | prev) +27 Jwarner talk contribs →Radiation therapy {{#subobject:6298df|Regimen=1}} |
|
m 15:14 | Esophageal cancer 2 changes history +21 [Jwarner (2×)] | |||
m |
|
15:14 (cur | prev) +10 Jwarner talk contribs →Definitive therapy | |||
m |
|
15:13 (cur | prev) +11 Jwarner talk contribs →Preceding treatment |
|
m 15:12 | Diffuse large B-cell lymphoma 5 changes history +574 [Jwarner (5×)] | |||
m |
|
15:12 (cur | prev) +1 Jwarner talk contribs →Lenalidomide monotherapy {{#subobject:e4284f|Regimen=1}} | |||
m |
|
15:11 (cur | prev) +230 Jwarner talk contribs →Relapsed or refractory, salvage therapy | |||
m |
|
15:06 (cur | prev) +61 Jwarner talk contribs | |||
m |
|
15:04 (cur | prev) +65 Jwarner talk contribs →Maintenance after upfront therapy | |||
m |
|
15:03 (cur | prev) +217 Jwarner talk contribs →Consolidation after upfront therapy |